Decrease in sales results in company’s acquisition of pharmaceutical facility
Fujifilm is reportedly buying a facility in Morrisville that makes ingredients used in biotechnology drugs, expanding the Japanese photography company's foothold in the Triangle's pharmaceutical industry.
Fujifilm has announced plans to acquire a contract manufacturing subsidiary of Merck that includes Diosynth's 110,000-square-foot factory on 80 acres. The factory makes products for pharmaceutical and biotech companies in the United States, Europe and Japan.
Merck acquired the Diosynth division in 2009 as part of its $49 billion purchase of rival Schering-Plough, according to newsobserver.com. Since then, Merck has been consolidating operations and cutting jobs to make that deal pay off.
Fujifilm is seeking to offset slowing sales of its digital cameras and equipment for medical scans by expanding into drug development, especially for biotech medicines.
Read the full-length article here.
- Edited by Amanda McLeman, Plant Engineering, www.plantengineering.com
- Events & Awards
- Magazine Archives
- Oil & Gas Engineering
- Salary Survey
- Digital Reports
Annual Salary Survey
After almost a decade of uncertainty, the confidence of plant floor managers is soaring. Even with a number of challenges and while implementing new technologies, there is a renewed sense of optimism among plant managers about their business and their future.
The respondents to the 2014 Plant Engineering Salary Survey come from throughout the U.S. and serve a variety of industries, but they are uniform in their optimism about manufacturing. This year’s survey found 79% consider manufacturing a secure career. That’s up from 75% in 2013 and significantly higher than the 63% figure when Plant Engineering first started asking that question a decade ago.